Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Ceftaroline-fosamil/Vancomycin

Thrombocytopenia and neutropenia

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Smith-Uffen M, et al. Presumptive diagnosis of MRSA bacteremia delays closure of symptomatic patent foramen ovale and leads to complications of antimicrobial therapy. Polskie Archiwum Medycyny Wewnetrznej 132 (Suppl.): 23-24, Jan 2022 [abstract] Smith-Uffen M, et al. Presumptive diagnosis of MRSA bacteremia delays closure of symptomatic patent foramen ovale and leads to complications of antimicrobial therapy. Polskie Archiwum Medycyny Wewnetrznej 132 (Suppl.): 23-24, Jan 2022 [abstract]
Metadaten
Titel
Ceftaroline-fosamil/Vancomycin
Thrombocytopenia and neutropenia
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56067-2

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Cemiplimab

Case report

Azathioprine

Case report

Aciclovir